Tocilizumab in refractory giant cell arteritis. Monotherapy versus combined therapy with conventional immunosuppressive drugs. Observational multicenter study of 134 patients
Monica Calderón-Goercke, Santos Castañeda, Vicente Aldasoro, Ignacio Villa, C. Moriano, Susana Romero-Yuste, Javier Narváez, Catalina Gómez‐Arango, Eva Pérez‐Pampín, R. Melero, E. Becerra, Marcelino Revenga, Noelia Álvarez-Rivas, Carles Galisteo, Francisca Sivera, Eugenio de Miguel, D. Prieto-Peña, Miguel Á. González‐Gay, José L. Hernández, Ricardo Blanco
Topics & Concepts
MedicineTocilizumabGiant cell arteritisRefractory (planetary science)Observational studyInternal medicineMulticenter studyDermatologyVasculitisRheumatoid arthritisRandomized controlled trialPhysicsAstrobiologyDiseaseVasculitis and related conditionsOtitis Media and Relapsing PolychondritisCoagulation, Bradykinin, Polyphosphates, and Angioedema